Cincinnati—The Second International Symposium on Inherited Diseases
of the Pancreas will take place on March 19—21 at the Hyatt Regency
Hotel. The scope and structure of this symposium is intended to spawn
interest, discussion, and collaborations that will benefit all patients
with pancreatic diseases. Participants will learn about current
concepts regarding hereditary pancreatic cancer, pancreatitis, and
pancreatic conditions related to cystic fibrosis. They will also hear
current concepts regarding genetics testing, prevention, therapeutic
intervention, and screening for tumors in these patient populations.
first International Symposium on Hereditary Pancreatitis marked a new
era in studies on inherited predisposition to pancreatic disease in
adults. The rapid expansion of information and new discoveries relevant
to hereditary pancreatitis, the diversity of pancreatic disease states
resulting from mutation in the cystic fibrosis gene, and the genetics
of pancreatic cancer have provided the foundation for this second
symposium," says Charles D. Ulrich, II, MD, assistant professor of
medicine and director of research, Division of Digestive Diseases,
University of Cincinnati.
This symposium is sponsored by the
University of Cincinnati Division of Digestive Diseases and Office of
Continuing Medical Education with support from the Midwest Multicenter
Pancreatic Study Group, the University of Pittsburgh Center for Genomic
Sciences, the Cystic Fibrosis Foundation, the American Digestive Health
Foundation, and Solvay Pharmaceuticals. For more information call (513) 558-5244 or (513) 677-2960.